Toll Free: 1-888-928-9744
Published: Apr, 2015 | Pages:
33 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Immune Design Corp. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Immune Design Corp. - Product Pipeline Review - 2015', provides an overview of the Immune Design Corp.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Immune Design Corp. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Immune Design Corp.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Immune Design Corp.'s pipeline products Reason To Buy - Evaluate Immune Design Corp.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Immune Design Corp. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Immune Design Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Immune Design Corp. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Immune Design Corp. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Immune Design Corp. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Immune Design Corp. Snapshot 5 Immune Design Corp. Overview 5 Key Information 5 Key Facts 5 Immune Design Corp. - Research and Development Overview 6 Key Therapeutic Areas 6 Immune Design Corp. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Pipeline Products - Out-Licensed Products 14 Out-Licensed Products/Combination Treatment Modalities 15 Immune Design Corp. - Pipeline Products Glance 16 Immune Design Corp. - Clinical Stage Pipeline Products 16 Phase I Products/Combination Treatment Modalities 16 Immune Design Corp. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 Immune Design Corp. - Drug Profiles 18 (ID-LV305 + ID-G305) 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 G-100 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 G-305 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 LV-305 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 G-103 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Immune Design Corp. - Pipeline Analysis 25 Immune Design Corp. - Pipeline Products by Target 25 Immune Design Corp. - Pipeline Products by Route of Administration 26 Immune Design Corp. - Pipeline Products by Molecule Type 27 Immune Design Corp. - Recent Pipeline Updates 28 Immune Design Corp. - Dormant Projects 30 Immune Design Corp. - Locations And Subsidiaries 31 Head Office 31 Other Locations & Subsidiaries 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 32 Disclaimer 33
List of Tables
Immune Design Corp., Key Information 5 Immune Design Corp., Key Facts 5 Immune Design Corp. - Pipeline by Indication, 2015 8 Immune Design Corp. - Pipeline by Stage of Development, 2015 9 Immune Design Corp. - Monotherapy Products in Pipeline, 2015 10 Immune Design Corp. - Combination Treatment Modalities in Pipeline, 2015 11 Immune Design Corp. - Partnered Products in Pipeline, 2015 12 Immune Design Corp. - Partnered Products/ Combination Treatment Modalities, 2015 13 Immune Design Corp. - Out-Licensed Products in Pipeline, 2015 14 Immune Design Corp. - Out-Licensed Products/ Combination Treatment Modalities, 2015 15 Immune Design Corp. - Phase I, 2015 16 Immune Design Corp. - Preclinical, 2015 17 Immune Design Corp. - Pipeline by Target, 2015 25 Immune Design Corp. - Pipeline by Route of Administration, 2015 26 Immune Design Corp. - Pipeline by Molecule Type, 2015 27 Immune Design Corp. - Recent Pipeline Updates, 2015 28 Immune Design Corp. - Dormant Developmental Projects,2015 30 Immune Design Corp., Other Locations 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.